The year 2024 marks an exceptional period of growth in academic activities related to vitiligo and pigmentary disorders. The Chang Gung Vitiligo Treatment Center continues to showcase its expertise and innovation on the global stage.

Next week, representatives from the Chang Gung Vitiligo Treatment Center will travel to Egypt to participate in the Vitiligo International Symposium (VIS), a prestigious biennial event. As invited speakers and session chairs, the team will proudly represent Taiwan, presenting their latest research findings and engaging in scholarly discussions with leading experts from around the world.

The center will share its groundbreaking research on the following topics:
1️⃣ Artificial Intelligence in Vitiligo
Exploring the potential of AI in diagnosing and treating vitiligo.

2️⃣ JAK Inhibitor Efficacy in Refractory Vitiligo
Evaluating the impact of small molecule drugs on treatment-resistant vitiligo.

3️⃣ Predictive Factors in the Recurrence of Vitiligo
Identifying key factors associated with vitiligo recurrence to enhance prognosis management.

4️⃣ EI-001 Human Anti-IFN Gamma Antibody
Investigating the future potential of anti-interferon gamma biologics in vitiligo treatment.

5️⃣ Feasibility of CRFF OCT in Vitiligo Grafting
Assessing the application of high-resolution optical coherence tomography in vitiligo grafting procedures.

The team gained invaluable insights at the previous VIS held in India two years ago and looks forward to building on that experience. This year’s participation underscores their commitment to advancing vitiligo care while sharing Taiwan’s expertise with the global medical community.

📌 Stay tuned for more updates and highlights from the conference!